生物正交化学
原位
化学
免疫疗法
降级(电信)
生物化学
嵌合体(遗传学)
蛋白质降解
蛋白质工程
细胞生物学
生物物理学
融合蛋白
组合化学
蛋白质生物合成
连接器
癌症免疫疗法
蛋白质-蛋白质相互作用
FKBP公司
细胞培养
化学生物学
氨基酸
纳米技术
纳米生物技术
催化作用
体内
HEK 293细胞
细胞存活
靶蛋白
作者
Jiasha Wu,Luyi Wang,Shiqin Jian,Rui Ji,Yan Zuo,Siyao Liu,Xiaochun Hu,Honggang Hu
出处
期刊:ACS Nano
[American Chemical Society]
日期:2026-05-11
卷期号:20 (20): 14828-14846
被引量:2
标识
DOI:10.1021/acsnano.6c04279
摘要
Targeting glutathione peroxidase 4 (GPX4) with traditional small-molecule inhibitors or conventional proteolysis-targeting chimeras (PROTACs) is limited by uncontrollable systemic toxicity. To overcome this, we engineered a nanosystem (GV@Ce6–Cu, GVCC) centered on the bioorthogonal in situ synthesis of a PROTAC, strictly governed by a tumor microenvironment (TME)-specific “AND” logic gate responsive to both overexpressed cathepsin B (CTSB) and elevated glutathione (GSH). Within the TME, CTSB specifically cleaves a peptide precursor into functional fragments, while GSH simultaneously reduces a codelivered Cu 2+ to the active Cu + catalyst. Only the concurrent action of both inputs enables the bioorthogonal ligation of the fragments in situ to form the active GPX4-degrading PROTAC. This precise synthesis orchestrates a cascade of functions. The in situ-generated PROTAC initiates ferroptosis by degrading GPX4; this effect is powerfully amplified by coreleased copper ions (driving cuproptosis) and by chlorin e6 (Ce6)-mediated photodynamic therapy (PDT), which together generate a massive reactive oxygen species burst. This cooperative induction of ferroptosis and cuproptosis, augmented by PDT, triggers robust immunogenic cell death. Consequently, GVCC treatment reprograms the immunosuppressive triple-negative breast cancer microenvironment and demonstrates potent synergy with anti-PD-L1 checkpoint blockade. This study establishes bioorthogonal in situ PROTAC synthesis as an effective precision strategy for cancer therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI